Theriva Biologics, Inc. (TOVX) announced Loss for full year of -$25.65 million
The company's bottom line totaled -$25.65 million, or -$19.03 per share. This compares with -$18.35 million, or -$28.48 per share, last year.
Theriva Biologics, Inc. earnings at a glance (GAAP) :
-Earnings: -$25.65 Mln. vs. -$18.35 Mln. last year.-EPS: -$19.03 vs. -$28.48 last year.
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.